These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
283 related articles for article (PubMed ID: 36949696)
1. [Expression of Tyrosine Kinase Receptor 2 in Oral Squamous Cell Carcinoma and the Effect on Cell Proliferation and Migration and Epithelial-Mesenchymal Transition Process]. Zheng M; Huang Y; Fei W; Shen Y; Nie X; Gao MY Sichuan Da Xue Xue Bao Yi Xue Ban; 2023 Mar; 54(2):342-349. PubMed ID: 36949696 [TBL] [Abstract][Full Text] [Related]
3. Inhibition of Akt activity induces the mesenchymal-to-epithelial reverting transition with restoring E-cadherin expression in KB and KOSCC-25B oral squamous cell carcinoma cells. Hong KO; Kim JH; Hong JS; Yoon HJ; Lee JI; Hong SP; Hong SD J Exp Clin Cancer Res; 2009 Feb; 28(1):28. PubMed ID: 19243631 [TBL] [Abstract][Full Text] [Related]
4. CD147 promotes proliferation and migration of oral cancer cells by inhibiting junctions between E-cadherin and β-catenin. Min A; Xiong H; Wang W; Hu X; Wang C; Mao T; Yang L; Huang D; Xia K; Su T J Oral Pathol Med; 2020 Nov; 49(10):1019-1029. PubMed ID: 32740991 [TBL] [Abstract][Full Text] [Related]
5. Butyrate promotes oral squamous cell carcinoma cells migration, invasion and epithelial-mesenchymal transition. Zang W; Liu J; Geng F; Liu D; Zhang S; Li Y; Pan Y PeerJ; 2022; 10():e12991. PubMed ID: 35223210 [TBL] [Abstract][Full Text] [Related]
6. FUT6 inhibits the proliferation, migration, invasion, and EGF-induced EMT of head and neck squamous cell carcinoma (HNSCC) by regulating EGFR/ERK/STAT signaling pathway. Wang Q; Liao C; Tan Z; Li X; Guan X; Li H; Tian Z; Liu J; An J Cancer Gene Ther; 2023 Jan; 30(1):182-191. PubMed ID: 36151332 [TBL] [Abstract][Full Text] [Related]
7. miR-146a promotes proliferation, invasion, and epithelial-to-mesenchymal transition in oral squamous carcinoma cells. Wang F; Ye LJ; Wang FJ; Liu HF; Wang XL Environ Toxicol; 2020 Oct; 35(10):1050-1057. PubMed ID: 32469461 [TBL] [Abstract][Full Text] [Related]
8. MiR-455-5p suppresses PDZK1IP1 to promote the motility of oral squamous cell carcinoma and accelerate clinical cancer invasion by regulating partial epithelial-to-mesenchymal transition. Hsiao SY; Weng SM; Hsiao JR; Wu YY; Wu JE; Tung CH; Shen WL; Sun SF; Huang WT; Lin CY; Chen SH; Hong TM; Chen YL; Chang JY J Exp Clin Cancer Res; 2023 Feb; 42(1):40. PubMed ID: 36737832 [TBL] [Abstract][Full Text] [Related]
9. CD47-SIRPα Signaling Induces Epithelial-Mesenchymal Transition and Cancer Stemness and Links to a Poor Prognosis in Patients with Oral Squamous Cell Carcinoma. Pai S; Bamodu OA; Lin YK; Lin CS; Chu PY; Chien MH; Wang LS; Hsiao M; Yeh CT; Tsai JT Cells; 2019 Dec; 8(12):. PubMed ID: 31861233 [TBL] [Abstract][Full Text] [Related]
10. hsa_circ_0072387 Suppresses Proliferation, Metastasis, and Glycolysis of Oral Squamous Cell Carcinoma Cells by Downregulating miR-503-5p. Han L; Cheng J; Li A Cancer Biother Radiopharm; 2021 Feb; 36(1):84-94. PubMed ID: 32302508 [No Abstract] [Full Text] [Related]
11. Overexpression of angiopoietin 2 promotes the formation of oral squamous cell carcinoma by increasing epithelial-mesenchymal transition-induced angiogenesis. Li C; Li Q; Cai Y; He Y; Lan X; Wang W; Liu J; Wang S; Zhu G; Fan J; Zhou Y; Sun R Cancer Gene Ther; 2016 Sep; 23(9):295-302. PubMed ID: 27492854 [TBL] [Abstract][Full Text] [Related]
12. PDGF-D/PDGFRβ promotes tongue squamous carcinoma cell (TSCC) progression via activating p38/AKT/ERK/EMT signal pathway. Zhang H; Sun JD; Yan LJ; Zhao XP Biochem Biophys Res Commun; 2016 Sep; 478(2):845-51. PubMed ID: 27507215 [TBL] [Abstract][Full Text] [Related]
13. Bovine lactoferrin reverses programming of epithelial-to-mesenchymal transition to mesenchymal-to-epithelial transition in oral squamous cell carcinoma. Chea C; Miyauchi M; Inubushi T; Okamoto K; Haing S; Nguyen PT; Imanaka H; Takata T Biochem Biophys Res Commun; 2018 Dec; 507(1-4):142-147. PubMed ID: 30415774 [TBL] [Abstract][Full Text] [Related]
14. Baicalein Inhibits Metastasis of Oral Squamous Cell Carcinoma Cells by Regulating ERK/ELK-1/Snail Signaling. Huang Y; Li F Discov Med; 2024 Jun; 36(185):1298-1305. PubMed ID: 38926116 [TBL] [Abstract][Full Text] [Related]
15. Elevated Expression of Zinc Finger Protein 703 Promotes Cell Proliferation and Metastasis through PI3K/AKT/GSK-3β Signalling in Oral Squamous Cell Carcinoma. Wang H; Deng X; Zhang J; Ou Z; Mai J; Ding S; Huo S Cell Physiol Biochem; 2017; 44(3):920-934. PubMed ID: 29176314 [TBL] [Abstract][Full Text] [Related]
16. [Expression of fibroblast growth factor receptor like 1 protein in oral squamous cell carcinoma and its influence on tumor cell proliferation and migration]. Zheng C; Shi CJ; Du LJ; Jiang YH; Su JM Hua Xi Kou Qiang Yi Xue Za Zhi; 2020 Oct; 38(5):558-565. PubMed ID: 33085242 [TBL] [Abstract][Full Text] [Related]
17. Effects of Allocryptopine on the Proliferation and Epithelial-Mesenchymal Transition of Oral Squamous Cell Carcinoma through m6A Mediated Hedgehog Signaling Pathway. Gong J; Wang C; Zhang F; Lan W J Environ Pathol Toxicol Oncol; 2022; 41(2):15-24. PubMed ID: 35695648 [TBL] [Abstract][Full Text] [Related]
18. FBXW7 inhibited cell proliferation and invasion regulated by miR-27a through PI3K/AKT signaling pathway and epithelial-to-mesenchymal transition in oral squamous cell carcinoma. Li C; Lin XF; Wang JN; Ren XS Eur Rev Med Pharmacol Sci; 2020 Apr; 24(7):3701-3709. PubMed ID: 32329846 [TBL] [Abstract][Full Text] [Related]
19. Role of miR-218-GREM1 axis in epithelial-mesenchymal transition of oral squamous cell carcinoma: An in vivo and vitro study based on microarray data. Wang Y; Jiang Y; Chen L J Cell Mol Med; 2020 Dec; 24(23):13824-13836. PubMed ID: 33107676 [TBL] [Abstract][Full Text] [Related]
20. Ribophorin II promotes the epithelial-mesenchymal transition and aerobic glycolysis of laryngeal squamous cell carcinoma via regulating reactive oxygen species-mediated Phosphatidylinositol-3-Kinase/Protein Kinase B activation. Zhou J; Zhang J; Zhang W; Ke Z; Lv Y; Zhang B; Liao Z Bioengineered; 2022 Mar; 13(3):5141-5151. PubMed ID: 35156537 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]